Surgical Science Sweden AB
STO:SUS

Watchlist Manager

Surgical Science Sweden AB

STO:SUS

Watchlist

Dividends

Price: 129.4 SEK 0.7%

Market Cap: 6.6B SEK

Have any thoughts about
Surgical Science Sweden AB?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 129.4 SEK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

SUS Alert

Surgical Science Sweden AB

129.4

+0.9 (+0.7%)

52 Week Range	113.7 193.3
Price Target

We'll email you a reminder when the closing price reaches SEK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Surgical Science Sweden AB

What unique competitive advantages
does Surgical Science Sweden AB hold over its rivals?

What risks and challenges
does Surgical Science Sweden AB face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Surgical Science Sweden AB.

What unique competitive advantages
does Surgical Science Sweden AB hold over its rivals?

What risks and challenges
does Surgical Science Sweden AB face in the near future?

Has there been any significant insider trading activity
in Surgical Science Sweden AB recently?

Summarize the latest earnings call
of Surgical Science Sweden AB.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Surgical Science Sweden AB.

Provide P/S
for Surgical Science Sweden AB.

Provide P/E
for Surgical Science Sweden AB.

Provide P/OCF
for Surgical Science Sweden AB.

Provide P/FCFE
for Surgical Science Sweden AB.

Provide P/B
for Surgical Science Sweden AB.

Provide EV/S
for Surgical Science Sweden AB.

Provide EV/GP
for Surgical Science Sweden AB.

Provide EV/EBITDA
for Surgical Science Sweden AB.

Provide EV/EBIT
for Surgical Science Sweden AB.

Provide EV/OCF
for Surgical Science Sweden AB.

Provide EV/FCFF
for Surgical Science Sweden AB.

Provide EV/IC
for Surgical Science Sweden AB.

Show me price targets
for Surgical Science Sweden AB made by professional analysts.

What are the Revenue projections
for Surgical Science Sweden AB?

How accurate were the past Revenue estimates
for Surgical Science Sweden AB?

What are the Net Income projections
for Surgical Science Sweden AB?

How accurate were the past Net Income estimates
for Surgical Science Sweden AB?

What are the EPS projections
for Surgical Science Sweden AB?

How accurate were the past EPS estimates
for Surgical Science Sweden AB?

What are the EBIT projections
for Surgical Science Sweden AB?

How accurate were the past EBIT estimates
for Surgical Science Sweden AB?

Compare the revenue forecasts
for Surgical Science Sweden AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Surgical Science Sweden AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Surgical Science Sweden AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of Surgical Science Sweden AB compared to its peers.

Compare the P/E ratios
of Surgical Science Sweden AB against its peers.

Discuss the investment returns and shareholder value creation
comparing Surgical Science Sweden AB with its peers.

Analyze the financial leverage
of Surgical Science Sweden AB compared to its main competitors.

Show all profitability ratios
for Surgical Science Sweden AB.

Provide ROE
for Surgical Science Sweden AB.

Provide ROA
for Surgical Science Sweden AB.

Provide ROIC
for Surgical Science Sweden AB.

Provide ROCE
for Surgical Science Sweden AB.

Provide Gross Margin
for Surgical Science Sweden AB.

Provide Operating Margin
for Surgical Science Sweden AB.

Provide Net Margin
for Surgical Science Sweden AB.

Provide FCF Margin
for Surgical Science Sweden AB.

Show all solvency ratios
for Surgical Science Sweden AB.

Provide D/E Ratio
for Surgical Science Sweden AB.

Provide D/A Ratio
for Surgical Science Sweden AB.

Provide Interest Coverage Ratio
for Surgical Science Sweden AB.

Provide Altman Z-Score Ratio
for Surgical Science Sweden AB.

Provide Quick Ratio
for Surgical Science Sweden AB.

Provide Current Ratio
for Surgical Science Sweden AB.

Provide Cash Ratio
for Surgical Science Sweden AB.

What is the historical Revenue growth
over the last 5 years for Surgical Science Sweden AB?

What is the historical Net Income growth
over the last 5 years for Surgical Science Sweden AB?

What is the current Free Cash Flow
of Surgical Science Sweden AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for Surgical Science Sweden AB.

SUS

Balance Sheet

Accounts Receivables

Surgical Science Sweden AB
Accounts Receivables

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

Surgical Science Sweden AB
Accounts Receivables Peer Comparison

Comparables:

EKTA B

CEVI

GETI B

ARJO B

STIL

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company		Accounts Receivables	CAGR 3Y	CAGR 5Y	CAGR 10Y
S	Surgical Science Sweden AB STO:SUS	Accounts Receivables kr96.3m	CAGR 3-Years 71%	CAGR 5-Years 51%	CAGR 10-Years N/A
	Elekta AB (publ) STO:EKTA B	Accounts Receivables kr5.9B	CAGR 3-Years 5%	CAGR 5-Years 4%	CAGR 10-Years N/A
	CellaVision AB STO:CEVI	Accounts Receivables kr105.2m	CAGR 3-Years 11%	CAGR 5-Years 10%	CAGR 10-Years 12%
	Getinge AB STO:GETI B	Accounts Receivables kr6.4B	CAGR 3-Years 3%	CAGR 5-Years -2%	CAGR 10-Years N/A
	Arjo AB (publ) STO:ARJO B	Accounts Receivables kr1.7B	CAGR 3-Years 5%	CAGR 5-Years -1%	CAGR 10-Years N/A
S	Stille AB STO:STIL	Accounts Receivables kr65.7m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years 23%

What is Surgical Science Sweden AB's Accounts Receivables?

Accounts Receivables
96.3m SEK

Based on the financial report for Jun 30, 2024, Surgical Science Sweden AB's Accounts Receivables amounts to 96.3m SEK.

What is Surgical Science Sweden AB's Accounts Receivables growth rate?

Accounts Receivables CAGR 5Y
51%

Over the last year, the Accounts Receivables growth was -27%. The average annual Accounts Receivables growth rates for Surgical Science Sweden AB have been 71% over the past three years , 51% over the past five years .

Surgical Science Sweden AB
STO:SUS

Surgical Science Sweden AB
Accounts Receivables

Surgical Science Sweden AB
Accounts Receivables Peer Comparison

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

See Also

What is Surgical Science Sweden AB's Accounts Receivables?

Accounts Receivables
96.3m SEK

What is Surgical Science Sweden AB's Accounts Receivables growth rate?

Accounts Receivables CAGR 5Y
51%

Company

Help

Tools

Stocks

Surgical Science Sweden AB STO:SUS

Surgical Science Sweden AB Accounts Receivables

Surgical Science Sweden AB Accounts Receivables Peer Comparison

Competitive Accounts Receivables Analysis Latest Figures & CAGR of Competitors

See Also

What is Surgical Science Sweden AB's Accounts Receivables? Accounts Receivables 96.3m SEK

What is Surgical Science Sweden AB's Accounts Receivables growth rate? Accounts Receivables CAGR 5Y 51%

Company

Help

Tools

Stocks

Surgical Science Sweden AB
STO:SUS

Surgical Science Sweden AB
Accounts Receivables

Surgical Science Sweden AB
Accounts Receivables Peer Comparison

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

What is Surgical Science Sweden AB's Accounts Receivables?

Accounts Receivables
96.3m SEK

What is Surgical Science Sweden AB's Accounts Receivables growth rate?

Accounts Receivables CAGR 5Y
51%